| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 生物制品(原料药及制剂产品)(元) | 1,964,412,393.25 | 2,693,527,810.55 | 1,223,532,404.36 | 2,360,202,125.13 |
| 特许经营权前期服务(元) | 2,936,503.84 | 135,337,835.49 | 1,395,594.84 | 99,373,826.49 |
| 化药(元) | 2,474,153.79 | 2,888,247.61 | - | - |
| 其他(元) | 96,972,591.89 | 213,593,911.46 | 89,964,846.05 | 148,460,999.43 |
| 营业成本(元) | ||||
| 生物制品(原料药及制剂产品)(元) | 424,340,810.61 | 631,843,281.14 | 294,534,129.15 | 617,617,965.33 |
| 特许经营权前期服务(元) | 244,778.07 | 6,658,618.31 | - | - |
| 化药(元) | 2,586,066.90 | 2,809,440.44 | - | - |
| 其他(元) | 63,705,359.04 | 125,194,928.98 | 54,564,641.85 | 79,803,449.86 |
| 毛利(元) | ||||
| 生物制品(原料药及制剂产品)(元) | 1,540,071,582.64 | 2,061,684,529.41 | 928,998,275.21 | 1,742,584,159.80 |
| 特许经营权前期服务(元) | 2,691,725.77 | 128,679,217.18 | 1,395,594.84 | 99,373,826.49 |
| 化药(元) | -111,913.11 | 78,807.17 | - | - |
| 其他(元) | 33,267,232.85 | 88,398,982.48 | 35,400,204.20 | 68,657,549.57 |
| 毛利率(%) | ||||
| 生物制品(原料药及制剂产品)(%) | 78.40 | 76.54 | 75.93 | 73.83 |
| 特许经营权前期服务(%) | 91.66 | 95.08 | - | - |
| 化药(%) | -4.52 | 2.73 | - | - |
| 其他(%) | 34.31 | 41.39 | 39.35 | 46.25 |
| 收入构成(%) | ||||
| 生物制品(原料药及制剂产品)(%) | 95.05 | 88.45 | 93.05 | 90.50 |
| 特许经营权前期服务(%) | 0.14 | 4.44 | 0.11 | 3.81 |
| 化药(%) | 0.12 | 0.09 | - | - |
| 其他(%) | 4.69 | 7.01 | 6.84 | 5.69 |
| 毛利构成(%) | ||||
| 生物制品(原料药及制剂产品)(%) | 97.73 | 90.47 | 96.19 | 91.21 |
| 特许经营权前期服务(%) | 0.17 | 5.65 | 0.14 | 5.20 |
| 化药(%) | -0.01 | 0.00 | - | - |
| 其他(%) | 2.11 | 3.88 | 3.67 | 3.59 |